Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy
Status:
Completed
Trial end date:
2019-07-08
Target enrollment:
Participant gender:
Summary
The main objectives of this non-interventional cohort field study are to evaluate
effectiveness of Eylea and to describe follow-up as well as treatment patterns in patients
with wAMD (wet age-related macular degeneration) in routine clinical practice in Italy for a
study population of "naïve" patients